Neostem (NBS) Reports Q2 EPS Loss of $0.13, Sales Fall Y/Y
Tweet
Share
E-mailGet Alerts NBS Hot Sheet
Price: $2.25 --0%
Financial Fact:
Selling, general, and administrative: 4.94M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Selling, general, and administrative: 4.94M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Neostem (NYSE: NBS) reported Q2 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $23.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- IDT Corp. (IDT) Misses Q4 EPS by 3c
- Accenture (ACN) Tops Q4 EPS by 10c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
